Atezolizumab, Cobimetinib, and Eribulin in Patients With Metastatic Inflammatory Breast Cancer
3 Tampilan
• 07/03/23
0
0
Menanamkan
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru